Valuation DexCom, Inc. Sao Paulo
Stocks
D1EX34
BRD1EXBDR004
Medical Equipment, Supplies & Distribution
|
Market Closed -
Sao Paulo
02:21:58 14/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 9.440 BRL | +1.40% |
|
+7.76% | +26.03% |
| 09/11 | Health Canada Approves Dexcom G7 for Use with Myloop, Powered by Camaps Fx | CI |
| 30/10 | DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 31,078 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 20.06% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 30,735 | 30,190 | 29,000 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 17.27% | -1.77% | -3.94% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 32.7x | 27.6x | 23x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.7x | 10.1x | 7.32x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.5x | 1.5x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.94x | 5.38x | 4.85x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.88x | 5.23x | 4.52x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 18.4x | 15.9x | 13.2x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 24.4x | 20.9x | 17.1x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 27.4x | 24.2x | 19.3x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.65% | 4.13% | 5.19% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.546 | 3.019 | 3.623 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,228 | 5,775 | 6,412 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,670 | 1,902 | 2,190 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,260 | 1,442 | 1,699 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 979.8 | 1,143 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -343.5 | -887.6 | -2,078 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 83.33 | 83.33 | 83.33 |
| Nbr of stocks (in thousands) | 3,87,688 | 3,86,258 | 3,86,374 | 3,90,595 | 3,90,016 | 3,72,951 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.48x | 4.19x | 15.73x | 2.42% | 19TCr | |
| 21.86x | 3.71x | 13.29x | 2.81% | 13TCr | |
| 26.94x | 4.79x | 16.44x | 1.15% | 12TCr | |
| 31.57x | 3.04x | 12.28x | 2.26% | 9.25TCr | |
| 18.53x | 0.22x | 13.79x | 0.68% | 6.85TCr | |
| 43.97x | 3.87x | 13.18x | 1.94% | 5.94TCr | |
| 46.33x | 11.64x | 32.65x | -.--% | 5.55TCr | |
| 28.86x | 7.15x | 18.14x | 1.39% | 4.96TCr | |
| 52.13x | 1.44x | 13.34x | -.--% | 3.47TCr | |
| Average | 33.96x | 4.45x | 16.54x | 1.41% | 9TCr | |
| Weighted average by Cap. | 31.83x | 4.29x | 15.92x | 1.75% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- D1EX34 Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
